Day One Biopharmaceuticals Inc (DAWN) support and resistance · rev $131.2M
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
This page maps Day One Biopharmaceuticals Inc (DAWN) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
DAWN currently screens at market cap $656.8M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new DAWN 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the DAWN quote page for the session range and the stock page for the full model.
Not investment advice.